Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for acute non-arteritic anterior ischemic optic neuropathy
ACTRN12607000181404Phase 3Active, not recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in non-arteritic anterior ischemic optic neuropathy (NAION) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Change in visual acuity. Started Jun 2006; status: active, not recruiting.
02
Drugs
memantine
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on ACTRN12607000181404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000181404.